Menlo Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results
REDWOOD CITY, Calif., March 03, 2020 (GLOBE NEWSWIRE) — Menlo Therapeutics Inc. (Nasdaq: MNLO), a late-stage biopharmaceutical company focused on […]
REDWOOD CITY, Calif., March 03, 2020 (GLOBE NEWSWIRE) — Menlo Therapeutics Inc. (Nasdaq: MNLO), a late-stage biopharmaceutical company focused on […]
NEW YORK, March 03, 2020 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for February 2020, on its […]
Board of directors announces acting chief executive officer Benjamin Wolin to serve as president and CEO Fourth quarter net sales of […]
SAN FRANCISCO, March 03, 2020 (GLOBE NEWSWIRE) — UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend […]
ATLANTA, March 03, 2020 (GLOBE NEWSWIRE) — Cardlytics, Inc., (NASDAQ: CDLX), a purchase intelligence platform that makes marketing more relevant […]
TORONTO, March 03, 2020 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device […]
INDIANAPOLIS, March 03, 2020 (GLOBE NEWSWIRE) — Infrastructure and Energy Alternatives, Inc. (“IEA” or the “Company”) (NASDAQ: IEA), a leading […]
PRINCETON, N.J., March 03, 2020 (GLOBE NEWSWIRE) — Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development […]
CHICAGO, March 03, 2020 (GLOBE NEWSWIRE) — Monroe Capital Corporation (Nasdaq: MRCC) (“Monroe”) today announced its financial results for the […]
CAMBRIDGE, Mass., March 03, 2020 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is genetically engineering […]